Geode Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.7M | Sell |
|
|||||
|
2025
Q2 | $24.4M | Buy |
|
|||||
|
2025
Q1 | $17.6M | Buy |
|
|||||
|
2024
Q4 | $27.9M | Buy |
|
|||||
|
2024
Q3 | $48.2M | Buy |
|
|||||
|
2024
Q2 | $51.3M | Buy |
|
|||||
|
2024
Q1 | $56.2M | Buy |
|
|||||
|
2023
Q4 | $60.2M | Buy |
|
|||||
|
2023
Q3 | $59.5M | Buy |
|
|||||
|
2023
Q2 | $72.8M | Buy |
|
|||||
|
2023
Q1 | $61.7M | Buy |
|
|||||
|
2022
Q4 | $55.5M | Buy |
|
|||||
|
2022
Q3 | $76.9M | Buy |
|
|||||
|
2022
Q2 | $66.9M | Buy |
|
|||||
|
2022
Q1 | $89.2M | Sell |
|
|||||
|
2021
Q4 | $146M | Buy |
|
|||||
|
2021
Q3 | $161M | Buy |
|
|||||
|
2021
Q2 | $181M | Buy |
|
|||||
|
2021
Q1 | $81.9M | Buy |
|
|||||
|
2020
Q4 | $46.9M | Buy |
|
|||||
|
2020
Q3 | $14.7M | Buy |
|
|||||
|
2020
Q2 | $13.8M | Buy |
|
|||||
|
2020
Q1 | $7.23M | Buy |
|
|||||
|
2019
Q4 | $8.05M | Sell |
|
|||||
|
2019
Q3 | $7.69M | Buy |
|
|||||
|
2019
Q2 | $8.25M | Buy |
|
|||||
|
2019
Q1 | $6.87M | Buy |
|
|||||
|
2018
Q4 | $4.91M | Buy |
|
|||||
|
2018
Q3 | $9.78M | Buy |
|
|||||
|
2018
Q2 | $7.17M | Buy |
|
|||||
|
2018
Q1 | $4.21M | Buy |
|
|||||
|
2017
Q4 | $3.77M | Buy |
|
|||||
|
2017
Q3 | $3.42M | Buy |
|
|||||
|
2017
Q2 | $1.5M | Buy |
|
|||||
|
2017
Q1 | $1.07M | Buy |
|
|||||
|
2016
Q4 | $941K | Buy |
|
|||||
|
2016
Q3 | $1.17M | Buy |
|
|||||
|
2016
Q2 | $1.44M | Buy |
|